CYBB and metabolic dysfunction-associated steatotic liver disease: In several pathological conditions, including non-alcoholic fatty liver disease (NAFLD), pneumonia, atherosclerosis, and neurodegenerative diseases, a pathogenetic interaction between LPS, oxidative stress, and activation of the enzyme NADPH oxidase 2 (NOX2) has been described.